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Abstract
Neutrophils are the first line of defense at the site of an infection. They encounter and kill microbes intracellularly upon
phagocytosis or extracellularly by degranulation of antimicrobial proteins and the release of Neutrophil Extracellular Traps
(NETs). NETs were shown to ensnare and kill microbes. However, their complete protein composition and the antimicrobial
mechanism are not well understood. Using a proteomic approach, we identified 24 NET-associated proteins. Quantitative
analysis of these proteins and high resolution electron microscopy showed that NETs consist of modified nucleosomes and
a stringent selection of other proteins. In contrast to previous results, we found several NET proteins that are cytoplasmic in
unstimulated neutrophils. We demonstrated that of those proteins, the antimicrobial heterodimer calprotectin is released in
NETs as the major antifungal component. Absence of calprotectin in NETs resulted in complete loss of antifungal activity in
vitro. Analysis of three different Candida albicans in vivo infection models indicated that NET formation is a hitherto
unrecognized route of calprotectin release. By comparing wild-type and calprotectin-deficient animals we found that
calprotectin is crucial for the clearance of infection. Taken together, the present investigations confirmed the antifungal
activity of calprotectin in vitro and, moreover, demonstrated that it contributes to effective host defense against C. albicans
in vivo. We showed for the first time that a proportion of calprotectin is bound to NETs in vitro and in vivo.
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Introduction
Neutrophils are an essential component of the innate immune
response since neutropenia or impairment of neutrophil function
results in microbial infections that are often fatal [1]. Microbes
engulfed by neutrophils are efficiently killed by reactive oxygen
species (ROS) and antimicrobial proteins within vacuoles [2].
Additionally, neutrophils [3] and two other granulocytes, mast
cells [4] and eosinophils [5], release web-like extracellular traps
that ensnare and kill microbes.
Neutrophil Extracellular Traps (NETs) are released during a
novel form of cell death that requires ROS produced by the
NADPH-oxidase complex [6]. During this process, the nucleus
decondenses and intracellular membranes disintegrate allowing
the mixing of nuclear and cytoplasmic components. Eventually,
the plasma membrane ruptures to release NETs, structures that
contain chromatin and granule proteins. The overall composition
of NETs has not been explored. Neutrophils of several species
make NETs [7,8,9] and they might be important in the immune
defense against bacteria and fungi [10,11,12,13]. Whereas bacteria
[3] and parasites [14] probably are killed by histones in NETs, in a
previous study we found that purified histones did affect Candida
albicans in vitro only poorly [13]. Thus, it remains to be determined
whether histones or other antifungal effectors in NETs kill or
inhibit fungi. This seems to be particularly of importance since
previous reports have demonstrated that histones and histone
peptides kill different fungal species such as Cryptococcus neoformans
and Candida tropicalis [15,16,17].
Fungal pathogens, in particular C. albicans, cause an increasing
number of severe infections with high mortality rates [18]. C.
albicans is an opportunistic pathogen that can be part of the normal
microbial flora of humans. In immunosuppressed patients the
microbe can use a variety of virulence factors that enables it to
exploit various host niches and to cause different diseases ranging
from cutaneous to systemic infections [19]. A key characteristic of
C. albicans is the ability to change growth morphology from
budding yeast to filamentous forms: pseudohyphae and true
hyphae [20]. A variety of external stimuli have been shown to
induce the yeast-to-hyphae transition, such as serum, alkaline pH
and temperatures above 37uC [21]. The ability to reversibly switch
between different morphologies upon external stimuli appears to
be essential for the virulence of C. albicans [22,23].
PLoS Pathogens | www.plospathogens.org 1 October 2009 | Volume 5 | Issue 10 | e1000639Using a proteomic approach, we analyzed the qualitative and
quantitative protein composition of NETs. We identified 24
different proteins, including the cytoplasmic calprotectin protein
complex (also called Mrp8/14-complex or S100A8/A9) that has
been shown previously by several groups to have potent
antimicrobial properties [24,25,26]. S100A8 and S100A9 belong
to the large group of S100 calcium-binding proteins and form a
heterodimer, calprotectin, which is abundant in neutrophils,
monocytes and early differentiation stages of macrophages [27].
In other cell types, such as keratinocytes and epithelial cells, the
expression can be induced under inflammatory conditions [28].
The antibacterial and antifungal activity of the complex is
reversible by Zn
2+ [29] and does not require direct contact to
the microbe [30,31]. Therefore, it is thought that calprotectin
chelates divalent metal ions that are required for microbial
growth. This defense mechanism has been termed nutritional
immunity [32]. Recently, Sroussi et al. proposed that the
antifungal activity of calprotectin may be increased by oxidative
stress [33].
Calprotectin is elevated in the extracellular fluids of patients
with inflammatory disorders such as rheumatoid arthritis and
vasculitis. Indeed, this complex is now used as a marker for
inflammation [34]. Recently, calprotectin was described as a
potential endogenous Toll-like receptor 4 (TLR-4) activator that
promotes lethal endotoxic shock [35].
Despite all these important extracellular functions the complex
lacks a secretion signal. A non-classical and tubulin-dependent
secretion mechanism was shown in monocytes activated by
inflammatory cytokines [36]. The mechanism by which this
cytoplasmic dimer derived from neutrophils is able to interact with
extracellular microbes in vivo is not completely understood. Here
we show that calprotectin is released as the major antifungal
protein in NETs. Our data indicate that at infection sites NET
formation is a mechanism which ensures the interaction between
cytoplasmic calprotectin and extracellular microbes at high local
concentrations.
Results
Qualitative analysis of the protein composition of NETs
We isolated neutrophils from healthy donors and induced them
to form NETs using phorbol myristate acetate (PMA). After gently
washing the NETs twice to remove unbound proteins, we
solubilized NET-bound proteins with DNase-1 (Figure S1). NET
proteins were digested with trypsin and analyzed by nano-scale
liquid chromatography coupled matrix-assisted laser desorption/
ionization mass spectrometry (nano LC-MALDI-MS). The identi-
fication quality is represented by the MS/MS spectrum of S100A9,
a subunit of calprotectin found with this approach (Figure S2 A). A
protein was considered to be associated to NETs when the
identification criteria (see Methods) were fulfilled in at least two
fromatotalofthreeindependentsamples.Weidentified24different
proteins (Table 1, NET Database: http://web.mpiib-berlin.mpg.
de/cgi-bin/pdbs/lc/index.cgi), nine of which were previously
shown to localize in NETs by immunofluorescence microscopy
[3,37], which correlates well with the results of our approach.
We identified proteins that have a nuclear, granular or
cytoplasmic localization in unstimulated neutrophils. Among the
nuclear components, we confirmed the presence of all four
subtypes of core histones and newly found the myeloid cell
differentiation antigen (MNDA). We also identified eight granular
proteins, five of which (neutrophil elastase (NE), lactotransferrin
(LTF), cathepsin G (CG), myeloperoxidase (MPO) [3] and more
recently proteinase 3 (PR3) [37]) were previously found associated
with NETs. Azurocidin, lysozyme C (LysC) and a-defensins were
not known to be NET components. Notably, we found eleven
cytoplasmic proteins; two glycolytic enzymes, catalase, five
cytoskeletal proteins and three S100 proteins. We confirmed
NET association of twelve proteins found in this study by indirect
immunofluorescence. Notably, the linker histone H1, bactericidal/
permeability increasing protein (BPI), pentraxin 3 (PTX-3) and
cathelicidin (CAP-18), were described as NET-associated
[3,38,39], but we did not find them with this approach.
Immunoblot analysis, however, confirmed the presence of BPI,
but not of PTX-3 or CAP-18 (Figure S2 B–D).
To evaluate the specificity of our approach, we analyzed all
purification steps. As previously described, activated neutrophils
release many unbound proteins into the supernatant [40]
(Figure 1A and B, lane 2) which were removed by two washes
with culture medium (Figure 1A and B, lane 3 and 4). NET-
associated proteins were specifically released by Dnase-1
(Figure 1A and B) with or without protease inhibitor cocktail
(lane 7 and 8 respectively). As an additional control for the
specificity of our approach we demonstrated that two cytoplasmic
proteins, glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and lactate dehydrogenase (LDH), were present in the supernatant
(Figure 1B, lane 2), but not in the nuclease-digested NETs
(Figure 1B, lanes 7 and 8).
To control the efficiency of the washing steps we increased the
number of washes from two to nine (1 ml/wash, Text S1) in
similar experiments as described above and determined the
amount of calprotectin, a very abundant protein in neutrophils,
in each fraction with ELISA. After NET formation calprotectin
was present in similar amounts in culture supernatants and in wash
1 (Figure S2 E). The calprotectin concentration dropped in wash
2. These data agreed well with the immunoblot data presented in
Figure 1B. However, we still detected minor amounts of
calprotectin in wash 3 (55 ng/ml) and 4 (21 ng/ml). The amount
decreased further in washes 5–7 until the calprotectin concentra-
tion reached the detection limit (1.6 ng/ml) of the assay in wash 8
and 9. Notably, from digestion of these intensely washed NETs
Author Summary
Neutrophils are phagocytes that disarm and kill microbes
by engulfing them. Less well characterized than their
phagocytic killing mechanisms is how neutrophils cope
with microbes that are too large to be internalized.
Notably, neutrophils may also kill or inhibit extracellularly
by releasing Neutrophil Extracellular Traps (NETs). NETs are
fibers made of chromatin (histones and DNA) decorated
with antimicrobial proteins. NETs ensnare and kill mi-
crobes, such as bacteria, fungi and parasites. We wanted to
find out if and how NETs control pathogenic fungi that can
form large filaments such as Candida albicans. We purified
all NET-bound proteins and identified 24 of them. We
found that calprotectin is the major antifungal NET-bound
protein. Calprotectin was known to be antimicrobial but
here we demonstrate that NET formation is a novel release
mechanism for this cytoplasmic protein. The NET matrix
comes in close contact with the fungi and the high local
concentration of calprotectin in the NETs supports the
antifungal activity. Furthermore, in mice calprotectin is
essential for an efficient antifungal response to Candida
albicans in skin, lung and systemic infections. In tissue
sections from these animals we detected NETs and NET-
associated calprotectin. Thus, our study gives more
insights into mechanisms how the immune system copes
with fungal pathogens.
NETs Release Calprotectin
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approximately 170 ng/ml calprotectin which equals 23% of the
total amount (720 ng/ml) according to our determination with the
same ELISA under the same conditions. This is 20-fold more
calprotectin than in wash 7 suggesting that calprotectin is bound to
NETs. Taken together, this indicates that we purified and
selectively enriched NET-associated proteins and that the NETs
contain at least 24 proteins 15 of which were identified as NETs
component for the first time (Table 1, marked in blue, and NET
Database).
Quantitative analysis of the protein composition of NETs
To determine the relative amounts of NET proteins we
quantified 15 of the 24 NET-associated proteins by immunoblot-
ting (Table 2, Figure S3, NET Database). We purified NET
proteins from neutrophils isolated from ten healthy donors. On
average, NETs derived from 10
12 neutrophils contained 3.58+/
20.28 g of protein and 2.24+/20.51 g of DNA. This indicates a
ratio of 1.67+/20.26 g of protein per gram of DNA.
The core histones H2A, H2B, H3 and H4, were the most
abundant proteins and account for 70% of all NET-associated
proteins. The molecular mass of these proteins is decreased by
approximately 2–5 kDa, when compared to histones present in the
nucleus (Figure 2A). This modification is specific, since the masses
of non-nuclear proteins do not change upon association with
NETs. (Figure 2A, S100A8 and NET Database). Moreover, the
stoichiometry of the four core histones is different in NETs as
compared to intact nuclei. In unstimulated neutrophils, the core
histones are present in similar amounts (Figure 2A, lane 2). In
contrast, on NETs, H3 and H4 are found in lower amounts than
H2A and H2B (Figure 2A, lane 7) and their molarity per gram
NET-derived DNA is different (Table 2, NET Database). These
observations correlated to high resolution Field Emission Scanning
Electron Microscope (FESEM) analyses (Figure 2B and C). NETs
consist of ‘‘smooth’’ stretches, probably only composed of histones
and DNA (Figure 2B, white box), interspersed with globular
domains that contain granular proteins [3]. The smooth stretches
showed periodical signal intensities that are approximately 5 nm
thick and 10 nm wide (Figure 2C). These dimensions are similar to
those of nucleosomes [41] suggesting that smooth NET stretches
are composed of stacked cylindrical nucleosomes. On different
areas we found intensities with a similar horizontal periodicity but
a lower vertical dimension consistent with the notion that the
histone composition was changed during NET formation
(Figure 2A).
The most abundant non-histone NET protein was NE and the
least abundant protein detected was catalase (5.24 and 0.02% of
total protein, respectively). The 15 proteins we quantified
Table 1. Summary of identified NET proteins.
Cellular localization Protein name Gene name Swissprot/TREMBL
Granules Leukocyte elastase ELA2 P08246
Lactotransferrin LTF P02788
Azurocidin AZU1 P20160
Cathepsin G CTSG P08311
Myeloperoxidase MPO P05164
Leukocyte proteinase 3 PR3 P24158
Lysozyme C LYZ P61626
Neutrophil defensin 1 and 3 DEFA-1 and -3 P59665, P59666
Nucleus Histone H2A H2A Q9NV63+
Histone H2B: a) Histone H2B H2B Q16778+
b) Histone H2B-like H2B Q3KP43, Q6GMR5
Histone H3 H3 Q71DI3+
Histone H4 H4 P62805+
Myeloid cell nuclear differentiation antigen MNDA P41218
Cytoplasm S100 calcium-binding protein A8 S100A8 P05109
S100 calcium binding protein A9 S100A9 P06702
S100 calcium-binding protein A12 S100A12 P80511
Cytoskeleton Actin (P and/or R) ACTB, ACTG1 P60709, P63261
Myosin-9 MYH-9 P35579
Alpha-actinin (1 and/or -4) ACTN1, ACTN4 P12814, O43707
Plastin-2 LCP1 P13796
Cytokeratin-10 KRT-10 P13645
Peroxisomal Catalase CAT P04040
Glycolytic enzymes Alpha-enolase ENO1 P06733+
Transketolase TKT P29401
Proteins that localize to NETs. Proteins are organized by their localization in unstimulated neutrophils. Those identified to be NET-associated for the first time in this
report are shown in blue. Swissprot/TREMBL accession numbers marked with a ‘‘+’’ denote possible forms of the protein that cannot be discriminated by this analysis.
We identified two distanced groups of histone H2B. The larger group of individual histone H2B types we refer to as H2B and the other type that is less well characterized
we refer to as ‘‘H2B-like’’. All possible accession numbers can be found in the NET Database (http://web.mpiib-berlin.mpg.de/cgi-bin/pdbs/lc/index.cgi).
doi:10.1371/journal.ppat.1000639.t001
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PLoS Pathogens | www.plospathogens.org 3 October 2009 | Volume 5 | Issue 10 | e1000639Figure 1. Identification of NET-associated proteins. (A) Silver stained SDS-PAGE and (B) immunoblots with samples from NET protein
purification procedure. Human neutrophils were stimulated to form NETs. Supernatants from unstimulated (lane 1) and stimulated (lane 2)
neutrophils; first wash (lane 3); second wash (lane 4); medium containing DNase-1 incubated with unstimulated neutrophils (lane 5); DNase-1-free
medium incubated with washed NETs (lane 6); medium containing DNase-1 incubated with washed NETs (lane 7); medium containing DNase-1
incubated with washed NETs including protease inhibitor cocktail (lane 8).
doi:10.1371/journal.ppat.1000639.g001
Table 2. Quantified NET proteins.
Protein name Molecular weight (KDa) mmoles (per g NET-DNA) % Molar amount mg protein (per g NET-DNA)
Histone H2A 16.1 23.6061.07 26.29 379.3617.3
Histone H2B 15.3 21.5060.77 23.95 298.9610.7
Histone H3 13.9 13.0261.39 14.50 199.2621.3
Neutrophil elastase 25.4 5.2460.85 5.84 133.0621.5
Histone H4 11.4 3.9660.39 4.41 45.264.5
S100A8 10.8 3.5960.48 4.00 38.865.2
Lactotransferrin 76.0 2.4660.28 2.74 186.6621.6
Azurocidin 23.8 2.3560.44 2.62 55.9610.6
Cathepsin G 26.6 2.2260,11 2.47 59.262.7
S100A9 13.2 1.2760.12 1.41 16.761.6
Myeloperoxidase 78.4 0.9160.07 1.01 71.365.3
Proteinase 3 24.0 0.6460.13 0.71 15.563.2
Actin 41.8 0.1560.02 0.17 6.360.9
Lysozyme C 14.5 0.1260.036 0.13 1.860.5
Catalase 59.8 0.0260.001 0.02 1.2560.07
Quantified NET proteins are listed according to their mmolar amounts normalized to the amount of NET-DNA. Additionally, the calculated amount as a percentage of
total NET protein content and the mass per g NET-DNA are shown. The data are representative mean values6mean deviation (n=3) from two independent
experiments.
doi:10.1371/journal.ppat.1000639.t002
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nine proteins and those that were potentially not identified in our
approach represent 9.7% of the total NET proteins. NETs
contained 39 ng of S100A8 and 17 ng of S100A9 per mg of DNA
after 2 washes (Table 2 and NET database). Since each well
yielded in average 3.8 mg DNA, we calculated 148 ng S100A8 and
Figure 2. Histones are altered during NET formation. NETs from human neutrophils were washed and digested with DNase-1. (A) The NET-
fraction (N) and the remaining pellet after DNase-1 digest (P) were analyzed by immunoblotting at the indicated time points. Unstimulated neutrophils
served as controls. All core histones have a reduced molecular mass (2–5 kDa less) in NETs compared to the pelletfraction andthe unstimulatedcontrol.
A representative experiment out of three in total is shown. (B) High-resolution SEM analysis of NETs which consist of smooth fibers (white box) and
globular domains (diameter 25–50 nm, arrows), scale bar=100 nm. (C) High-resolution FESEM analysis of smooth stretch of a singular NET-fiber. Signal
intensities were profiled vertically and horizontally showing similar diameters to nucleosomes (depicted as cartoon structure models taken from [41],
with approximate horizontal and vertical diameters of 5 nm and 10 nm, respectively). One experiment out of two is shown.
doi:10.1371/journal.ppat.1000639.g002
NETs Release Calprotectin
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213 ng/well. This correlates well with the quantification of
calprotectin by ELISA (Figure S4 E) which yielded 170 ng/well.
It is possible that the difference observed is due to the different
number of washes in the two experiments.
Taken together, the different quantification methods are
comparable.
Calprotectin localizes in NETs
The association of calprotectin to NETs suggests that the
complex is released during a specific form of holocrine secretion
[42] referred to as NETosis [43]. Using indirect immunofluores-
cence we verified that calprotectin is released through NET
formation in vitro (Figure 3A–F). A calprotectin-heteroduplex-
specific antibody [44] confirmed that the dimer was cytoplasmic
(red), and it overlapped with granular MPO (green) in the compact
cytoplasm of unstimulated cells (Figure 3A). There was also a faint
calprotectin signal within the nucleus (DNA stain, blue) consistent
with the fact that cytoplasmic proteins with a mass below 30 kDa
can diffuse through the nuclear pore complex. Thirty minutes after
stimulation the neutrophils flattened as a sign of activation
revealing a granular staining for MPO and a more dispersed
cytoplasmic staining for calprotectin (Figure 3B). After stimulation
for 1 hour, we observed partial colocalization of MPO and
calprotectin in the cytoplasm (Figure 3C). This increased two
hours after activation, when the chromatin decondensed and the
nuclear membrane disassembled. At this time point calprotectin,
MPO and DNA colocalized (Figure 3D). A proportion of the
MPO signal remained in the area between the plasma membrane
and the decondensed nucleus. Three and 4 hours post-activation,
when the plasma membrane ruptured, calprotectin, DNA and
MPO colocalized on NETs (Figure 3E–F).
To determine whether calprotectin is released during NET cell
death or before the plasma membrane ruptures, we compared
neutrophils that were treated either with PMA to stimulate NET
formation [3] or with the microbial peptide formyl-met-leu-phe
(f-MLP) to stimulate degranulation [40]. At the indicated time
points we monitored neutrophil cell death by quantifying extra-
cellular LDH (Figure 3G) and solubilized NET-bound proteins by
adding Dnase-1 (Figure 3H). We subsequently collected the
supernatants containing both unbound and NET-bound proteins
to determine the total release of the indicated proteins during
degranulation and NET formation. We analyzed the samples by
immunoblotting and probed for the calprotectin subunits S100A8
and S100A9 as well as for two granular proteins, MPO and LTF
(Figure 3H). Thirty minutes after f-MLP treatment, neutrophils
released MPO and LTF, but not S100A8 nor S100A9. Four hours
after f-MLP treatment, minor amounts of S100A8 and S100A9
appear in the supernatants and less than 10% of the cells were
dead. During NET formation, MPO and LTF were secreted in
low amounts before S100A8 and S100A9 were released confirm-
ing that neutrophils also degranulate upon PMA-activation [40].
Significant amounts of extracellular calprotectin were only found 3
to 4 hours after stimulation, when 40 and 70% of the neutrophils
respectively were dead. Furthermore, we determined how much of
the total calprotectin amount present in the neutrophil actually
binds to NETs. After stimulation we quantified S100A9 released
into the supernatant, bound to NETs and remaining in the cell
remnants by quantitative immunoblots. Approximately 30% of the
total S100A9 was bound to NETs (Figure 3I). Equivalent amounts
of S100A9 were found in the supernatants and in the nuclease-
resistant cell remnants (Figure 3I). This agrees with a previous
report showing that after nuclease treatment, a proportion of
chromatin remains within the debris of the neutrophil [6]. We
obtained similar results for S100A8 (data not shown). Moreover, a
calprotectin specific ELISA (Figure S2 E) confirmed the finding
that similar amounts of calprotectin are in NETs (170 ng/ml)
compared to unbound in the culture supernatant (200 ng/ml) and
that this corresponds to 23% and 28% of the total amount of
calprotectin respectively. Taken together, this demonstrates that
approximately one third of calprotectin in vitro is released from
neutrophils in NETs.
Calprotectin is a major antifungal component of NETs
As we have reported previously NETs can control the growth of
C. albicans yeast and hyphal forms [13] and more recently this has
been demonstrated for Aspergillus nidulans conidia and hyphae as
well [45]. Additionally, we have now added Cryptococcus neoformans
to this list of NET inhibited fungi (Figure S4 A). However, the
mechanism behind the antifungal activity remained unclear. In
this study we confirmed the previous results by exposing C. albicans
to NETs at different multiplicities of infection (MOI) and at
different temperatures to induce yeast-form and hyphal growth
(Figure S4 B and C). Under all conditions the antifungal activity
of NETs was very similar reducing CFU counts approximately
100-fold, but not when the NETs were degraded with nucleases
(Figure S4 D). We confirmed the antifungal activity of NETs
against hyphae macro- and microscopically (Figure S4 E and F).
As expected, hyphae grew in media but this growth was inhibited
when they were incubated with NETs. We corroborated the anti-
candidal activity of NETs and showed similar results measuring
the viability of C. albicans hyphae with the tetrazolium dye XTT
(Figure S4 G–I). This method, unlike CFU enumeration, does not
require the dispersion of the hyphae [46].
We confirmed that NETs made by neutrophils stimulated with
C. albicans contain calprotectin, lactotransferrin and catalase
(Figure S4 J). This suggests that NETs have a qualitatively similar
composition regardless of the stimulus used to activate the
neutrophil.
Calprotectin chelates essential metal ions, such as Zn
2+ and
Mn
2+ resulting in reduced microbial growth [30,31]. Consistent
with this mechanism of action the antifungal activity of NETs was
inhibited by increasing concentrations of Zn
2+ (Figure 4A) or
Mn
2+ (Figure 4B). The direct role of calprotectin in NETs was
tested with immunodepletion experiments. We purified NET
proteins by DNase-1 treatment and concentrated the samples 10-
fold with 3.5 kDa cut-off membranes. The samples were incubated
with a mixture of immobilized antibodies directed against the
individual subunits S100A8 and S100A9 (Figure 4C). Immuno-
depletion of calprotectin, but not treatment of NET preparations
with isotype-matched controls, completely abrogated the growth-
inhibitory activity of NET proteins showing that this dimer is a
major antifungal component of NETs. It is important to note that
immunoblotting of the supernatant showed that S100A9, but not
lactotransferrin, was depleted (Figure 4C). A complementary assay
where C. albicans viability was measured using XTT confirmed the
result of the CFU based assay (Figure S4 H). Furthermore, NETs
made by calprotectin-deficient mice inhibited C. albicans growth
less efficiently than wild-type mouse NETs (Figure 4D) which was
confirmed with an XTT assay as well (Figure S4 I). Notably,
neutrophils from both genotypes made NETs with similar
efficiency (Figure S5 A–F).
The antimicrobial activity of calprotectin does not require direct
contact between microbe and protein, which is consistent with its
inability to bind microbial surfaces [30,31]. Regardless, at high
concentration this chelator is more efficient. Therefore, we tested
whether NET-bound calprotectin binds to microbes. Seeded
neutrophils were induced to release NETs. We collected the
NETs Release Calprotectin
PLoS Pathogens | www.plospathogens.org 6 October 2009 | Volume 5 | Issue 10 | e1000639Figure 3. Neutrophils release calprotectin by forming NETs. (A–F) Confocal images of human neutrophils without stimulation (A), after 0.5 h (B),
1h( C), 2 h (D), 3 h (E) and 4 h (F) after activation. Samples were stained with antibodies specific for the calprotectin heteroduplex (red) and for MPO
(green). DNA was stained with DRAQ5 (blue). Calprotectin localizes to the cytoplasm and partially to the nucleus (A, arrow). After stimulation for 0.5 h (B)
the neutrophils flattened and formed numerous vacuoles. This reveals a granular staining for MPO and a more dispersed cytoplasmic staining for
calprotectin. After stimulation for 1 h (C) the neutrophils round up slightly. The MPO and calprotectin stain partially overlap in the cytoplasm. After
stimulation for 2 h (D), calprotectin, MPO and nuclear DNA start to colocalize in the decondensed nucleus (purple). After 3 h (E)a n dm o r es oa f t e r4h( F)
of stimulation,the cellmembraneruptures and calprotectin is released inNETs colocalizing withMPO and DNA.Scale bar=10 mm; one experiment out of
two is shown. (G–I) Subunits of calprotectin S100A8 and S100A9 are released after cell death during NET formation and not by degranulation. NET
formation was induced with PMA and degranulation using formyl-met-leu-phe (f-MLP). (G) Neutrophil death was monitored by quantification of LDH
activity in supernatants calculated as means6s.d. (n=3). (H) Release of S100A8, S100A9, lactotransferrin (LTF) and myeloperoxidase (MPO) were analyzed
by immunoblotting. one experiment out of two is shown. (I) Quantification of immunoblots using 2D densitometry analyzing S100A9 protein
preparations from supernatants (lane 1), MNase-digested NETs (lane 2) and cell remnants indigestible for MNase (lane 3). Values were calculated as
means6s.d. (n=3) from one experiment out of two.
doi:10.1371/journal.ppat.1000639.g003
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soluble calprotectin. The NETs were subsequently washed twiceand
digested with MNase, a non-processive nuclease, to generate NET
fragments. We exposed the indicated fungi to these NET fragments
or supernatants containing soluble calprotectin and pelleted the
microbes afterwards. The microbial pellets were washed three times.
Immunoblotting in Figure 4E shows that NET-associated, but not
soluble S100A9, binds to the fungi. We obtained similar results for
S100A8 (data not shown). Taken together, these data indicate that
calprotectin is a major antifungal NET component. We conclude
that the presentation of this dimer in NETs provides a high local
concentration on the surface of microbes.
Calprotectin is required for innate antifungal defense
We addressed the role of calprotectin in C. albicans infections
comparing wild-type to S100A9 knockout mice. These animals
transcribe the mRNA for S100A8 but are deficient in S100A8 and
S100A9 protein [47]. C. albicans exploits different host niches and
we investigated three of them: (i) subcutaneous inoculation, which
leads to confined abscesses; (ii) intranasal infection, which causes
pulmonary candidiasis and (iii) intravenous challenge, which
mimics disseminated systemic candidiasis.
The dimensions of the abscess lesions were measured at
indicated time points. On average, the area of the lesions in
calprotectin –deficient mice were twice as large (200 mm
2)a s
compared to those of wild-type animals (100 mm
2) measured at
two, four and six days after inoculation (Figure 5A–E). At day four,
60% of the abscesses in calprotectin-deficient mice ulcerated as
indicated by extensive necrosis which also included the epidermis
(Figure 5A). Consistent with a less severe progression, abscesses of
wild-type animals were restricted to subcutaneous areas without
involvement of outer skin layers (Figure 5D). Eight days after
Figure 4. Calprotectin is a major antifungal component in NETs. Human neutrophils were induced to make NETs, washed and infected with
C. albicans (MOI 0.01) and incubated overnight at 30uC (yeast-form growth). Antifungal activity was determined by counting CFU. Increasing
concentrations of ZnSO4 (A) and of MnCl2 (B) abolished the antifungal activity of human NETs. Shown are means6s.d. (n=3) from one representative
experiment out of three. (C) Purified human NET proteins were concentrated and depleted of calprotectin using immobilized anti-S100A8 and
anti-S100A9 combined. Controls were incubated with mouse IgG1 isotype matched antibodies. C. albicans was incubated with these extracts overnight
at 37uC (hyphal growth) and CFU were determined. Shown are means6s.d. (n=3) from one experiment out of two. The inset shows an immunoblot
confirmationof the depletion. Theblots were probed for S100A9andlactotransferrin (LTF). Thelanes arearranged in the same order as indicated for the
antifungal assay below the graph. (D) Mouse neutrophils isolated either from wild-type or calprotectin-deficient mice were induced to make NETs and
then infected with C. albicans (MOI 0.02) incubated overnight at 37uC (hyphal growth) and CFU counts were determined; n. d.=no detectable CFU.
Shown are means6s.d. (n=3) from one experiment out of two. (E) Co-precipitation assays of indicated fungi incubated with NET-bound calprotectin
(produced by MNase treatment) or soluble calprotectin. Microbes were pelleted, supernatants removed and washed pellets were analyzed using
immunoblots against S100A9. Shown are means6s.d. (n=3) of one representative experiment out of three.
doi:10.1371/journal.ppat.1000639.g004
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PLoS Pathogens | www.plospathogens.org 8 October 2009 | Volume 5 | Issue 10 | e1000639Figure 5. Calprotectin is required for antifungal immunity. (A–D) Subcutaneous abscesses induced with C. albicans of representative
calprotectin -deficient (a and b) and wild-type (c and d) mice at days 2, 4, 6 and 8 post infection (p.i.). (E) the area of the abscess lesions of
calprotectin-deficient animals compared to wild type was monitored over 8 days p.i. (n=10); abscesses of calprotectin-deficient animals are
significantly larger at days 2 (P=0.0007), 4 (P=0.0012), 6 (P=0.0003) but not at day 8. (F) calprotectin-deficient mice are more susceptible to
intranasal challenge with C. albicans than wild-type mice (n=10, P=0.0001). (G) Fungal load in the lungs after intranasal challenge with C. albicans is
significantly higher in calprotectin-deficient compared to wild-type mice (n=11; P=0.048). (H) Calprotectin-deficient mice are more susceptible to
intravenous challenge with C. albicans than wild-type mice (n=10, P=0.0159).
doi:10.1371/journal.ppat.1000639.g005
NETs Release Calprotectin
PLoS Pathogens | www.plospathogens.org 9 October 2009 | Volume 5 | Issue 10 | e1000639inoculation, the size of the abscesses in calprotectin-deficient and
wild-type mice was similar, indicating that calprotectin is essential
for the initial phase of the disease but that eventually other
mechanisms clear the infection. Interestingly, in about 30% of the
infected knockout mice, but not in wild-type controls, infection
spread from the original abscess to surrounding areas of the skin
(Figure S6). In our experimental settings neutrophil recruitment
(Figure S5 G) and NET formation (Figure S5 A–F) was similar in
knockout and wild-type animals.
In pulmonary candidiasis, wild-type mice show disease
symptoms within three days but recover and survive. In contrast,
calprotectin-deficient mice carried a significantly higher fungal
load than wild-type controls (Figure 5F) and succumbed to
C. albicans (Figure 5G).
Intravenous challenge is lethal in both calprotectin-deficient and
wild-type mice. However, the knockout animals died significantly
earlier (Figure 5H), suggesting that also in deep-seeded infection
sites, the antimicrobial activity of calprotectin contributes to
containment of fungal growth. This is consistent with a previous
report that calprotectin reduces bacterial load in systemic
staphylococcal infection [31]. We conclude that calprotectin is
required for an effective acute antifungal response.
NETs released during C. albicans infection contain
calprotectin
We tested whether NET formation is a route of calprotectin
release in vivo during subcutaneous (Figure 6A–F) and pulmonary
C. albicans infection (Figure 6G–M). Histological analysis of 6 day
old abscesses showed fungal foci surrounded by neutrophils
(Figure 6A). Using staining with hematoxylin and eosin (H &E),
we observed abundant extracellular DNA in web-like structures in
these areas (Figure 6B). To confirm that these structures were
NETs, the samples were labeled with antibodies directed against
MPO (green) and histones (blue) and analyzed by immunofluo-
rescence microscopy. Labeling with anti-S100A9 antibodies
demonstrated that these structures also contain calprotectin
(Figure 6, C–F).
In infected lungs, there was a strong neutrophil infiltration into C.
albicans colonized bronchioles one day after challenge. These areas
showed web-like structures of extracellular DNA (Figure 6 G
and H). MPO and histones (Figure 6M, arrow), as well as
calprotectin(Figure 6I–l) colocalized in these structures that unfold
into the lumen of the bronchioles. To demonstrate that C. albicans
and NETs interact in the lumen of bronchioles we analyzed these
sectionsbyScanningElectronMicroscopy(SEM)(Figure7A).Areas
colonized by C. albicans show web-like structures that cover fungal
surfaces (Figure 7B and C). These structures have a very similar
morphology and dimension to those observed for NETs in vitro.
Taken together these observations demonstrate that NETs and C.
albicans interact in vivo and that these NETs contain calprotectin. We
propose that release and NET-association of calprotectin from
neutrophils could contribute to contain fungal infections.
Discussion
The analysis presented here identified 24 NET-associated
proteins. Nine of the 24 proteins were described previously as
NET-associated which correlates well to our approach. Fifteen
proteins were hitherto unknown to be NET-bound and their
association to NETs was confirmed by immunoblotting and
indirect immunofluorescence (NET Database). The data under-
score the specificity and reproducibility of the analysis. Moreover,
the composition of the identified NET proteins was very similar
among different neutrophil donors (NET Database).
The small number of identified NET proteins is surprising since
the neutrophil cell membrane ruptures during the process of NET
release. Additionally, we used mild washing conditions for the
isolation. Therefore, the protein incorporation into NETs appears
to be selective. We found that, in addition to five nuclear proteins,
the NETs contain eight cationic granule proteins. Furthermore,
we identified eleven cytoplasmic proteins which have neutral to
acidic isoelectric points. This suggests that charge is not an
exclusive requirement for binding to NETs.
In previous reports histone H1 [3], bactericidal/permeability
increasing protein (BPI) [3], cathelicidin (CAP-18) [37,39] and
pentraxin 3 (PTX-3) [38] have been described as NET-associated
proteins. In contrast, we did not find these proteins in our MS
approach. We further investigated these proteins by immunoblot
(Figure S2B–C). We did not obtain clear results for histone H1
because commercially available anti H1-antibodies are cross-
reactive with other histones (data not shown). This remains to be
clarified. We could, however, detect the 25 kDa cleavage product
of BPI in both neutrophil lysates and NET extracts. The failure of
MS analysis to detect BPI remains unclear (Figure S1B). Notably,
we detected CAP-18 and PTX-3 in neutrophil lysates but not in
NET extracts. Therefore the presence of these two proteins in
NETs should be further investigated. It is possible that these
proteins are very loosely attached to NETs, that they are present in
very low amounts, that they were lost during the isolation
procedure or that the MS analysis failed to detect them. Notably,
neither by immunoblotting nor by MS did we find GAPDH, a
very abundant cytoplasmic and highly cationic protein. This
supports the assumption that NET binding is not exclusively
mediated by charge.
Quantification by immunoblots showed that 15 NET proteins
comprised 90% of the total protein amount in NETs, indicating
good coverage. Detection of 1.25 ng of catalase per mg NET-DNA
underscored the sensitivity of the approach. As the amounts of
NET proteins were similar in different donors the approach was
also reproducible (NET Database). More importantly this suggests
that NETs do not assemble randomly and are similar in many
individuals.
The core histones are the major protein components in NETs
as shown by the quantitative analysis. However, we found a
reduction of the molecular mass of NET-associated compared to
chromatin histones, possibly caused by post-translational modifi-
cations. Indeed, histone H3 is deiminated during NET formation
in HL60 cells but this remains to be confirmed in primary
neutrophils [48]. Additionally, the stoichiometry of the four
histones is different in NETs when compared to chromatin. There
is less H3 and less H4 in NETs than in chromatin, but the
significance of these differences remain unclear. High resolution
FESEM correlated with this finding. We determined a transverse
periodicity in individual NET-fibers that was similar to the actual
dimensions of intact and partially degraded nucleosomes.
The role of some of the identified cytoplasmic proteins in NETs
is unknown but there are indications for potential functions.
Enolase, for example, has been found to be a plasminogen
activator on leukocyte surfaces, although the secretion mechanism
is unknown [49]. NET-association could explain how enolase is
released allowing it to participate in tissue remodeling at
inflammatory sites.
We identified S100A8 and S100A9 that form the heterodimer
calprotectin as NET-associated proteins by MS analysis and by
indirect immunofluorescence. The dimer lacks a secretion signal
and localizes to the cytoplasm as well as partially to the nucleus of
unstimulated neutrophils. Therefore, the proteins must be released
in order to function as an antimicrobial protein against
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PLoS Pathogens | www.plospathogens.org 10 October 2009 | Volume 5 | Issue 10 | e1000639Figure 6. Calprotectin is present in C. albicans induced NETs in vivo. Wild-type mice were challenged subcutaneously (A–F) or intranasally
(G–L). (A,B, G and H) Hematoxylin & Eosin (H & E) stainings of sections in areas with strong neutrophil infiltration show extracellular DNA (hematoxylin
positive) representing NETs and indicated with arrows, scale bars 50 mm in (A,G) and 20 mm in (B,H). Confocal images of indirect immunofluorescence
from sections of abscesses 6 days after subcutaneous challenge (C–F) and lungs 24 h after intranasal challenge (I–L) stained with primary antibodies
against S100A9 (red), MPO (green) and histone (blue). NETs are web-like and diffuse areas where all signals superimpose indicated by white arrows.
Scale bars=20 mm.
doi:10.1371/journal.ppat.1000639.g006
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[50] and other cells [36] in response to specific stimuli was
previously reported. Our data, however, establish NET formation
as a hitherto unrecognized mechanism of calprotectin release in
neutrophils. Interestingly, incubation of C. albicans with neutrophils
was reported to increase extracellular calprotectin and, simulta-
neously decrease neutrophil viability [51]. The release mechanism,
however, remained unknown. Consistent with these data we
reported that C. albicans induces neutrophils to form NETs and die
in the process [13,52]. Here, we demonstrate that NET formation
induced by C. albicans during infection is a novel route for release
and presentation of calprotectin in vivo. We additionally showed
that calprotectin tightly binds to NETs as several intense washes
cannot remove calprotectin from NETs (Figure S2 E) or NET-
bound calprotectin from fungal surfaces (Figure 4E). In contrast
the unbound proportion of calprotectin released during NET
formation does not adhere to fungal surfaces. These findings
suggest that calprotectin, although it is abundant in unstimulated
neutrophils, specifically interacts with NETs. We determined that
30 and 23% of the total calprotectin was NET-associated by
immunoblot densitometry (Figure 3I) and ELISA (Figure S2E
respectively). These values indicate that a significant proportion of
the protein complex associates with NETs. Additionally, approx-
imately the same amount of calprotectin is released to the
supernatant. Thus, probably 50–60% of total cellular calprotectin
might become extracellular during NET formation. It is important
to note that with other methods previous publications determined
the total amount of calprotectin to be approximately 5 mg/10
6
human neutrophils [53,54]. Here we report approximately a
ten-fold lower amount of calprotectin (0.43 mg/10
6). This differ-
ence could be due to the methodology, donor variation and the
technique to count cells. Our functional assays on the inhibition of
C. albicans growth by NETs suggest that calprotectin in NETs
might have a biological implication due to the high local
concentration and close contact to the microbe.
In agreement with the findings discussed above we showed that
calprotectin is a major antifungal protein in NETs affecting
C. albicans and C. neoformans. Addition of Zn
2+ or Mn
2+ and
immunodepletion of calprotectin abrogated the antifungal activity
of NETs. This is consistent with previous reports showing that
calprotectin is microbiostatic in vitro because it chelates ions
[24,25,26,30]. Notably, an enhancement of calprotectin’s antifun-
gal activity by oxidative stress has been reported recently [33].
This could as well be the case in NETs, since the release requires a
robust oxidative burst to occur before [6]. Other NET proteins
were not affected by calprotectin depletion (Figure 4C), but
nonetheless NETs contain more antifungal proteins, such as
azurocidin and LTF. Interestingly, addition of Fe
2+ did not have
an impact on C. albicans in our experimental settings (data not
shown), suggesting that calprotectin, rather than LTF, controls
C. albicans under these conditions. This is probably also true for
C. neoformans. Fractionations of neutrophil compartments revealed
previously that azurophilic granule extract inhibited cryptococcal
growth to 80% and cytoplasmic extract to 70% [55]. The group
identified calprotectin as the one single effector in the cytoplasm
responsible for the strong inhibition correlating well with our
findings. Whether other proteins contribute to the antifungal
activity of NETs still remains to be determined (Figure 4D).
Moreover, our data demonstrate for the first time that calpro-
tectin is required for the innate immune defense to C. albicans
infections. We detected abundant NETs in subcutaneous abscesses
(Figure 6A–F), lungs after pulmonary challenge (Figure 6 G–M)
and kidneys from systemic candidiasis (data not shown), and we
propose that they prevent the spread of C. albicans. This might be
Figure7. Fine structure of C. albicans induced NETs in pulmonary
infection. (A–C) SEM analysis of sections from C. albicans infected
mouse lungs 24 h after intranasal challenge. (A) Image shows a
bronchiole colonized with C. albicans and infiltrated by host immune
cells,b=bronchiole. (B) High resolutionimageof boxedarea in(n)shows
respiratory epithelium of the bronchiole colonized with C. albicans yeast-
form (arrow) and hyphae (arrowhead). (C) High resolution image of
boxed area in (O) showing NETs covering fungal surfaces (arrow). Scale
bars in (N)=100 mm, in (O)=10 mm and in (P)=2 mm.
doi:10.1371/journal.ppat.1000639.g007
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be engulfed and is consistent with our previous finding that hyphae
are more potent NET inducers as yeasts [52]. Thus, we conclude
that NET formation could serve as an additional neutrophil-
mediated anti-hyphal mechanism complementing the previously
described damage of hyphae by oxidative products and the
myeloperoxidase system [56,57]. The NET-released calprotectin
reduces C. albicans growth correlating well with the more severe
disease symptoms we observed in calprotectin-deficient mice as
compared to wild type: increased abscess sizes upon subcutaneous
challenge and higher fungal loads in lungs upon intranasal
challenge. Indeed, the importance of NETs in reducing dissem-
ination seems likely to be similar to that observed in streptococcal
pneumonia [10]. This is consistent with a stronger survival
phenotype of calprotectin in pulmonary compared to systemic
infection, where C. albicans was disseminated from the outset. We
and others determined neutrophils as a major source of
calprotectin in infected tissue under the given conditions (data
not shown, [31]). However, calprotectin has been reported to be
expressed by other myeloid and epithelial cells and to be involved
in numerous other immune-related functions, such as chemotaxis,
regulation of the NADPH oxidase complex, activation of Toll-like
receptor 4 and induction of apoptosis [35,58,59,60]. Any of these
functions may contribute to the phenotypes in C. albicans infection
we report here. So far we have not identified a component that is
exclusively required for NET formation but not other neutrophil
functions. Therefore, we do not have a tool to determine the actual
contribution of NET-associated calprotectin in the described
infection phenotypes. We propose that differential localization of
calprotectin, e. g. unbound and NET-bound, may enable the
protein to be multi-functional.
Our analysis revealed a simple, stable and reproducible
composition of NETs. These data are likely to help investigate
the functions of NETs in infections and in other disorders such as
autoimmune diseases.
Materials and Methods
Mice, cells and strains
S100A9
2/2 mice [47] that are deficient in both calprotectin
subunits S100A8 and S100A9 protein were backcrossed 7 times
into C57 BL/6. These mice and C57 BL/6 controls were bred in
our animal facility. All animal experiments were in compliance
with the German animal protection law in a protocol approved by
the Landesamt fur Gesundheit und Soziales, Berlin. Human
peripheral blood neutrophils and mouse bone marrow derived
neutrophils were isolated as described [6,61]. We used C. albicans
clinical isolate SC 5314 [62]. C. neoformans strain DSM 11959 was
obtained from the German Collection of Microorganisms and
Cell Cultures (DSMZ). C. albicans was cultured overnight in YPD
(1% yeast extract, 2% bacto peptone and 2% glucose) at 30uC
and C. neoformans in the same medium at 37uC. Cells were washed
3 times in PBS prior to the experiments. Cell numbers were calcu-
lated by OD600 correlation (C. albicans:1O D 600=3 610
7 cells/ml;
C. neoformans:1O D 600=6 610
7 cells/ml). For experiments with
neutrophils and NETs C. albicans was either incubated at 37uCt o
i n d u c eh yp h a eo ra t3 0 uC to preserve yeast-form growth. C. neoformans
was always incubated at 37uC. All infection assays were performed in
RPMI medium.
Purification of NET proteins
Human neutrophils were seeded in 12-well tissue culture plates
to a density of 1.7610
6 ml
21 (RPMI 1640 without phenol red).
1.7610
6–3.4610
6 (according to 1–2 wells) and 1.7610
7 (according
to 10 wells) neutrophils were used for analytical and MS
identification respectively. Neutrophils were activated with
20 nM PMA for 4 h at 37uC in a 5% CO2 atmosphere. Each
well was carefully washed twice after removing the supernatant by
pipetting 1 ml of fresh and pre-warmed RPMI into the well along
the wall of the well. Each wash was incubated for 10 min at 37uC.
Subsequently the NETs were digested for 20 min in 1 ml RPMI
with 10 U/ml DNase-1 (Worthington). DNase-1 was stopped with
5 mM EDTA (final concentration). The samples were centrifuged
at 3006g to remove whole cells and then at 16,0006g to remove
debris. Proteins were acetone precipitated. Four matched samples
from different wells were pooled together and transferred to a
30 ml glass corex tube and 16 ml of ice-cold acetone (220uC) was
added. For precipitation samples were incubated overnight at
220uC and then centrifuged at 10 0006g for 30 min at 4uC. The
protein pellet was washed with 1 ml 80% acetone buffered in
20 mM Tris-HCl pH 8.0 and solubilized in 120 ml SDS loading
buffer or prepared for MS identification as described below.
For verification of our purification procedure we followed each
step of the isolation procedure by analysis of the respective sample
using silver stained SDS electrophoresis and immunoblotting. We
harvested all steps including the supernatant after 4 h incubation,
the washes 1 and 2, and the NET digests. As controls (i) NETs
were mock-digested with nuclease-free RPMI and (ii) unstimulated
neutrophils that did not release NETs were washed twice and
incubated with RPMI containing 10 U/ml Dnase-1 for 20 min at
37uC. Each sample was derived from one well containing 1.7610
6
neutrophils in a volume of 1 ml. Four samples out of 4 wells were
pooled, acetone precipitated, solubilized in 120 ml SDS loading
buffer and boiled for 3 min. To account for potential protein loss
due to proteolytic activity in the samples a complete purification
procedure was performed in the presence of protease inhibitor
cocktail (Sigma P1860; 1:200) added to the wells 2 h after
stimulation start as described above. Protease inhibitor cocktail
was additionally present in all media used for washing and
digestion. For analysis of the purification steps we loaded 30 mlo f
each pooled sample (equaling 1 well and 1.7610
6 neutrophils) on
SDS protein gels (Tris-HCl 10–20%). The gels were either silver
stained as described elsewhere [63] or immunoblotted by
transferring to a PVDF membrane (Immobilon 40; Millipore).
The immunoblots were performed as described in detail for the
quantitative blots below. The following primary antibodies were
used: a-elastase (Calbiochem 481001, 2 mg/ml), a-azurocidin
(Sigma N5662, 0.5 mg/ml), a-histone H2B (Upstate 07-371,
1 mg/ml), a-S100A8 combined with a-S100A9 (Acris BM4029
and BM4027, both at 2.5 mg/ml), a-catalase (Sigma C0979, 1 mg/ml),
a-GAPDH (Labfrontier LF-PA0018, 0.5 mg/ml), a-LDH (Abcam
ab7639, 1 mg/ml). As secondary antibodies horseradish-peroxidase-
conjugated F(ab’)2 fragments (Jackson ImmunoResearch) were used
in 1:20 000 dilutions.
For MS analysis NET proteins from 3 different donors were
purified independently in the absence (donor 1–3, named sample
1–3) or presence of the protease inhibitor cocktail indicated above
(donor 1–2, named sample 4 and 5).
DNA-concentration, neutrophil elastase activity and reactive
oxygen species (ROS) were measured as described previously [6].
Sample preparation and digestion for MS
Samples 1–5 (acetone precipitates from NET-purifications) were
solubilized in 40 ml of 500 mM triethylammonium bicarbonate
buffer pH 8.5 (TEAB) and reduced with 2 ml of 50 mM tris-
(2-carboxyethyl)phosphine (TCEP) for 60 min at 60uC. After
alkylation with 1 ml of 200 mM methyl methanethiosulfonate
(MMTS) at RT for 10 min each sample was incubated overnight
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500 mM TEAB. The reaction was stopped with 1 ml of a 10%
TFA solution to obtain a final concentration of TFA of
approximately 0.2%. The sample was centrifuged for 10 min at
138006g and the supernatant used for LC/MS analysis.
Nano-LC/MALDI-MS
The samples were analyzed by bottom-up nano-LC/MALDI-MS
as described in detail in the NET Database. Proteins were
digested with trypsin and the resulting peptides separated by
nano-LC (Dionex). Peptides were fractionated (Probot microfrac-
tion collector, Dionex) and analyzed with a 4700 Proteomics
Analyzer (Applied Biosystems) MALDI-TOF/TOF instrument.
The criterion for the identification of a protein was a minimum
number of 3 peptides fulfilling the Mascot homology criteria.
Candidates with two peptides fulfilling these criteria were verified
by checking the fragmentation rules, such as hypercleavage sites
(Asp, Glu, Pro), the appearance of common immonium masses
and mass losses [64]. A protein was considered as localizing to
NETs only when found in at least 2 independent samples from
different donors. Exceptions are MNDA, actinin and lysozyme C.
MNDA and actinin were identified with one peptide in
independent samples only, however the peptide is unique to
both proteins within the IPI-database. Presence of lysozyme C in
NETs was verified by immunoblotting. The MS analysis is
described in more detail on the NET database and in the
supporting materials.
Quantification of NET proteins
NET-associated proteins were quantified by immunoblot as
described [65]. Neutrophils were purified from 10 different
healthy donors, proteins were quantified using the DC assay
(Biorad) and DNA was quantified with Pico Green
TM (Invitrogen)
[6]. We isolated NET proteins as described in ‘Purification of
NET-proteins’. From each donor we prepared 12 times 1.7610
6
neutrophils each seeded in 1 ml RPMI per well in a 12 well tissue
culture plate. NETs from 10 wells were digested with 5 U/ml
MNase (Fermentas), a non-processive nuclease that cuts DNA at
linker sites. 2 wells were mock-digested with nuclease-free medium
as controls. We measured 3 independent pools made from 3
different donors each to average samples. For each quantification,
the 3 averaged samples and 6 different concentrations of the
respective purified protein, used as a standard, were loaded on the
same SDS-protein gel (Tris-HCl 10–20%). The gel was transferred
to a PVDF-membrane (Immobilon 40; Millipore) in a liquid
transfer system for 2 h at 80 V. The membrane was blocked for
1 h in PBS with 5% skim milk powder, washed 3 times in PBS
with 0.05% Tween-20 (PBST). Primary antibodies (listed in the
NET Database) were diluted in PBST with 1% BSA (PBST-BSA)
and incubated with the membrane for 1h at room temperature or
at 4uC over night. After 3 washes in PBST horseradish-peroxidase-
conjugated F(ab’)2 fragments (Jackson) were used as secondary
antibodies and incubated for 30 min. The blots were developed
with chemiluminescence and detected in a LAS 3000 camera
(Fujifilm Europe). The signal intensities of the bands were
analyzed by 2D densitometry (array imager software 4.15, Raytest)
and the concentration calculated based on the purified protein
standards in a linear range of analysis. The amount of sample was
adjusted to be within this range. To confirm the reproducibility of
our quantification approach, we prepared a separate batch of
pooled NET proteins from additional 5 donors and quantified
again 7 randomly chosen NET proteins producing comparable
results (NET Database).
Purified proteins as standards for quantitative
immunoblots
Recombinant human S100A8 and S100A9 for quantification
were purified as previously described [66]. cDNA of human
S100A8 and S100A9 in the plasmid pQE32 (C. Kerkhoff) were
amplified by standard PCR using primers with HindIII and NdeI
restriction sites at either end (S100A8: AGTCCTAAGCTTC-
TACTCTTTGTGGCTTTCTT, ATTACACATATGATGTT-
GACCGAGCTGGA; S100A9: ATCTAACATATGATGACTT-
GCAAAATGTCGCAGC, ATCTTCAAGCTTTTAGGGGGT-
GCCCTCCC). The PCR products were cloned into the expres-
sion vector pET28a+ (Invitrogen) and confirmed by sequencing.
We purchased recombinant core histones from Upstate, catalase
purified from human erythrocytes (Sigma-Aldrich) and all other
proteins purified from human neutrophils (Athens Research and
Technology).
High resolution FESEM analysis of NET fine structure
Human neutrophils were seeded on 12-mm cover slips and
stimulated with PMA for 4 hours. After fixation (2.5% glutardial-
dehyde), specimens were contrasted using repeated changes of
0.5% OsO4 and 0.05% tannic acid. Specimens were then
dehydrated in a graded ethanol series and subjected to critical
point drying. After coating with platinum/carbon, specimens were
analyzed in a Leo 1550 field emission scanning electron
microscope (FESEM, Zeiss SMT). Peripheral NET areas with
individual NET fibers were recorded at high magnification and
the obtained images were analyzed using the SmartSEM software
(Zeiss SMT).
Release of calprotectin
1.7610
6 ml
21 human neutrophils were seeded in 1 ml RPMI
medium containing 10 U/ml DNase-1 in 12 well tissue culture
plates. For each condition to be tested three wells were seeded with
neutrophils (n=3). They were stimulated to form NETs using
20 nM PMA, or to degranulate using 5 mM f-MLP at 37uCi na
5% CO2 atmosphere similar to [40]. Dnase-1 was present to
collect all released proteins, also the ones that are bound to NETs.
At the indicated time points the supernatants were collected.
Hundred ml aliquots were used to quantify LDH activity in the
samples using the Cytotoxicity Assay
TM (Promega) as a marker for
cell death [67,68]. As 100% control for LDH we lysed the same
amount of neutrophils in 1 ml RPMI with 0.1% Triton X-100 and
measured 100 ml. The rest of the samples were acetone
precipitated. Precipitates were boiled in 30 ml SDS sample buffer
and analyzed by immunoblotting using anti-S100A8 (Acris
BM4029, 2.5 mg/ml), anti-S100A9 (Acris BM4027, 2.5 mg/ml),
anti-LTF (Sigma-Aldrich L3262, 2 mg/ml) and anti-MPO (DAKO
A0398, 2 mg/ml) antibodies.
To determine the relative amounts of calprotectin in the
supernatant after NET formation and in NETs we seeded 1.7610
6
neutrophils per well and induced them to make NETs for 4 hours.
We collected the supernatant and washed the cells twice. The
washes were discarded. Then we digested the NETs with nuclease
in the same volume and removed the supernatant again after
20 min. Subsequently, we added 200 ml reducing SDS protein
sample buffer to the remaining debris in the wells and scratched
them thoroughly and boiled for 3 minutes. As 100% control we
lysed the same amount of neutrophils in 400 ml protein sample
buffer and boiled as well. The supernatant and the NET digest
were lyophilized overnight and also resuspended in 200 ml sample
buffer. 40 ml of each fraction was loaded and subjected to SDS
PAGE and immunoblotting with an anti-S100A9 antibody. The
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as described under ‘‘Quantification of NET proteins’’. The relative
amounts were calculated.
Antimicrobial activity of NETs
5610
5 ml
21 human or murine neutrophils were stimulated with
20 nM PMA for 4 h at 37uC in a 5% CO2 atmosphere to form
NETs in 24 well tissue culture plates. Supernatants were then
removed, NETs were washed twice with 1 ml RPMI and microbes
were added at a multiplicity of infection (MOI) of 0.01 if not stated
differently in 500 ml of RPMI per well. Samples C. albicans were
incubated overnight at 30uC to induce yeast-form growth or at
37uC to induce hyphal growth. NETs showed to be similarly
antifungal at both temperatures (Figure S4) and purified
calprotectin as well (data not shown). Assays with C. neoformans
were incubated only at 37uC. After incubation overnight the
microbes were plated on YPD agar plates to determine colony
forming units (CFU) or an XTT assay was performed as shown in
Figure S4. For assays in Figure 4 A & B C. albicans and NETs were
incubated at 30uC.
Immunodepletion of calprotectin from NETs
Twenty times 5610
5 human neutrophils wereseeded into 24 well
tissue culture plates each in 500 ml RPMI and stimulated with
20 nM PMA for 4h at 37uC in a 5% CO2 atmosphere to form
NETs. Supernatants were removed, NETs were washed twice with
1 ml RPMI and digested with 500 ml 10 U/ml DNase-1 each. The
digested NET proteins were pooled into two 5 ml fractions and
concentrated 10-fold on filter columns with a 3.5 kDa cut-off to a
volume of 500 ml. The concentrated samples wereincubated for 2 h
either with a combination of anti-S100A8 and anti-S100A9 (Acris
BM4029 and BM4027, 10 mg each), or isotype mouse IgG1 as a
control (Sigma M5284), immobilized on 100 ml magnetic sepharose
beads (Pierce). After incubation, the samples were diluted back to
the original volume using fresh medium to complement metal ions.
CFU were determined after incubation of these samples overnight
with C. albicans. Viability of C. albicans was also monitored using the
XTT assay as stated in supporting material Figure S4. The
immunodepletion was evaluated by immunoblotting. Samples were
tested for the presence of calprotectin (Acris BM4027, 2.5 mg/ml)
and lactotransferrin (Sigma-Aldrich L3262, 2 mg/ml) as a control.
Co-precipitation assay of free and NET-bound
calprotectin
1.7610
6 ml
21 human neutrophils were stimulated with 20 nM
PMA for 4h at 37uC in a 5% CO2 atmosphere to form NETs in
1 ml RPMI. NET-free supernatants after incubation were
removed and kept. NETs were washed twice with 1 ml RPMI
and digested in 1 ml RPMI with 5 U/ml MNase for 20 min to
obtain fragments of NETs. NET-free supernatants and digested
NET fragments were incubated on a rolling wheel with 3610
7 C.
albicans yeasts and C. neoformans from YPD overnight cultures
previously washed 3 times in PBS. After 30 min the microbes were
pelleted, the supernatants removed and washed three times in
fresh medium. These new supernatants were acetone-precipitated.
Precipitates from supernatants and microbial pellets were boiled in
SDS sample buffer and analyzed by immunoblotting using anti-
S100A8 and anti-S100A9 antibodies (Acris BM4029 and
BM4027, both at 2.5 mg/ml) as described above.
Infections and immunohistochemistry
For analysis of abscess formation 10 anesthetized animals per
group were shaved on the back and subcutaneously infected with
5610
7 C. albicans. Abscesses were measured with a caliper at the
indicated time points. Pulmonary candidiasis was induced by
intranasal challenge of anesthetized animals with 5610
7 C. albicans
and systemic candidiasis by intravenous injection to the tail vein
with 5610
5 C. albicans in 10 animals per group. Inoculation doses
were determined by CFU counts after plating. For intranasal and
intravenous challenge, survival was monitored daily. For fungal
load, lungs from 11 mice per group were macerated and CFU
determined 3 days after intranasal challenge. For histology of
pulmonary infections lungs were removed 24 h after intranasal
challenge and 6 days after subcutaneous challenge abscesses were
removed. Tissue samples were fixed in 2% formalin, dehydrated,
embedded in paraffin, sliced to 5 mm, rehydrated and stained with
hematoxylin and eosin (H & E). For immunostainings, samples
were rehydrated, subjected to antigen retrieval and incubated with
primary antibodies directed against calprotectin subunits S100A8
and S100A9 (produced in house), MPO (DAKO A0398) and
histone (Santa Cruz 8030). These were detected with secondary
antibodies coupled to Cy2, Cy3 or Cy5. DNA was detected with
DRAQ5
TM (Biostatus).
For fine structural analysis of paraffin-embedded tissue samples,
5 mm sections were rehydrated, postfixed with glutaraldehyde,
contrasted using repeated changes of 0.5% OsO4 and 0.05%
tannic acid, dehydrated in a graded ethanol series, critical-point
dried and coated with 5 nm platinum/carbon.
For immunostainings with human neutrophils, 1610
5 cells were
seeded on 13 mm glass cover slips, stimulated with 20 nM PMA
and fixed in 2% formalin at the indicated time points. Specimens
were blocked with 3% cold water fish gelatin, 5% donkey serum,
1% BSA, 0.25% TWEEN 20 in PBS, incubated with primary
antibodies directed against S100A8/A9 complex (Acris BM4025)
and MPO (DAKO A0398) and then washed. Primary antibodies
were detected with species-specific secondary antibodies and DNA
with DRAQ5
TM. Specimens were analyzed using a SP5 confocal
microscope (Leica).
Statistical analysis
One-way analysis of variance (ANOVA) with Bonferroni post-
tests was applied when multiple groups were compared and two-
tailed Student’s t-test was used for analysis of two groups. For non-
parametrically distributed data, the two-tailed Mann-Whitney test
was used. Survivals of infected mice were determined by the log-
rank test. Differences were considered statistically significant at
P,0.05. All statistical tests were performed using GraphPad Prism
version 4.02.
Supporting Information
Figure S1 Optimization of NET protein purification. Human
neutrophils were induced to make NETs. (A) The optimal time
point for isolation of NET proteins was determined by monitoring
DNA amount and neutrophil elastase (NE) activity at the indicated
time points. Four hours after stimulation, both DNA amount
and NE activity reached a maximum. This time point was
chosen for purification and identification of NET proteins. (B–C)
Different nucleases were compared. DNase-1 (B) and MNase (C), a
non-processive nuclease, digest NETs to release a maximum of
2.5 mg/ml DNA. Thus we used 10 U/ml Dnase-1 for protein
identifications. For a stable DNA concentration in all quantitative
analyses we used 5 U/ml MNase and normalized protein concen-
tration to DNA concentration. NETs were digested for different
amounts of time. Both Dnase-1 (D) and MNase (E) released a
maximum of DNA before 10 min of digest. To ensure complete
degradation of NETs 20 min were used for all experiments. The
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confirmed in a silver-stained SDS-PAGE analysis to be optimal at
10 U/ml and 20 min for a maximal protein yield. Shown are
means6s.d. (n=3) of representative experiments from two.
Found at: doi:10.1371/journal.ppat.1000639.s001 (4.40 MB TIF)
Figure S2 Mass spectrometry (MS) identification quality and
immunoassays to verify the absence or presence of proteins in
NETs. (A) Representative identification of NET protein S100A9
by LC-MS/MS. We obtained 51% sequence coverage from 8
MS/MS spectra and a Mascot ion score of 102. We show a
representative MS/MS spectrum of one peptide mass (1806.9532).
In this case, identification was confirmed by 9 y-ions in series and
11 b-ions, and the immonium ion of His (H). We evaluated the
NET association of (B) bactericidal/permeability increasing
protein (BPI), (C) pentraxin 3 (PTX-3) and (D) cathelicidin
CAP-18 that have been described as NET-associated [3,4,37,38],
but were not found in our MS approach. BPI and CAP-18 are
endogenously cleaved by neutrophil proteinases into a 25 kDa and
a 5 kDa (LL-37) cleavage product [2]. We immunoblotted
neutrophil (PMN) lysates, NET extracts and purified proteins as
positive controls. Human neutrophil granular extract (hNGE) was
used as positive control for the presence of BPI, as well as
recombinant human PTX-3 and purified human LL-37 peptide.
We confirmed NET association of BPI, but not of PTX-3 and
CAP-18. (E) Quantification of calprotectin. We confirmed that
calprotectin was a bona fide NET protein by washing the NETs
until unbound calprotectin was not detectable using an enzyme-
linked immunosorbent assay (ELISA) from Hycult. The data are
the average of two independent experiments (means6s.d., n=4),
bdl=below detection limit (1.6 ng/ml).
Found at: doi:10.1371/journal.ppat.1000639.s002 (0.42 MB TIF)
Figure S3 NET Protein quantification. Representative quanti-
tative immunoblots for S100A8 (A) and MPO (E) showing six
different protein amounts of the standard protein as well as a NET
sample in triplicate. The signal intensities (B and F) were plotted
against the amount of standard protein within a linear range (C for
S100A8 and G for MPO). The resulting equation was used to
calculate the respective amounts of proteins as means from three
different samples (D and H). The protein amounts (D and H) are
specified as mg or mmoles referred to the amount of DNA within
the sample. The DNA amount is the mean of all samples used for
this quantification. One sample equals the amount of NETs
isolated from 1.7610
6 human neutrophils. Similar analyses of all
the quantified proteins are available on the NET database.
Found at: doi:10.1371/journal.ppat.1000639.s003 (0.98 MB
DOC)
Figure S4 Antifungal activity and composition of NETs is similar
under different conditions (MOI or temperature) and stimuli (PMA
or C. albicans). Human neutrophils were induced to make NETs and
washed twice. C. albicans and NETs were incubated overnight in all
assays either at 30uC to preserve yeast-form growth or at 37uCt o
induce hyphal growth. (A) Cryptococcus neoformans or C. albicans were
added to NETs with a MOI of 0.04, incubated overnight at 37uCa n d
CFU determined, for C.n.+/2NETs P,0.01, for C.a.+/2NETs
P,0.05. (B) C. albicans was added to NETs and incubated to induce
hyphal growth. NETs inhibit C. albicans hyphae at a MOI of 0.04 and
0.01 similarly. (C) C. albicans was added to NETs and incubated to
preserve yeast-form growth. NETs inhibit C. albicans y e a s ta taM O I
of 0.2, 0.04 and 0.01 similarly. (D) Addition of MNase to NETs
significantly reduced inhibition of C. albicans yeast, P,0.01. (A–D)
Shown are means6s.d. (n=3) from one representative experiment
out of three. (E) Representative tissue culture plate and (F) light
microscopic image with growing C. albicans hyphae in the absence
(top) or presence of NETs (bottom). (G–I) Antifungal NET assays
using XTT [46] we confirmed that NETs also reduce C. albicans
growth under hyphae inducing conditions at 37uCo n l yi nt h e
absence of 0.5 mMZ n
2+ for +/2NETs at 0 mMZ n
2+ P,0.001 (G).
NET protein extracts inhibited hyphal growth significantly stronger
than calprotectin-depleted extracts, for +/2 depletion P,0.01 (H).
NETs from wild-type mouse neutrophils reduced hyphal growth
20-fold whereas S100A9-knockout neutrophils only reduced growth
3-fold, for WT vs. KO P,0.001 (I). Shown are means6s.d. (n=3)
from one experiment out of two. (J) Human neutrophils were induced
to make NETs overnight using either 20 nM PMA or C. albicans
(MOI 2) in the presence of protease inhibitors. NET proteins were
purified and protein concentrations of samples were determined and
equal amounts loaded. Immunoblots probed for lactotransferrin
(LTF), cathepsin G (CG), calprotectin and catalase indicated a similar
protein composition of NETs independent of the stimulus.
Differences in amounts of individual proteins might be caused by
an overall higher protein concentration in samples from C. albicans
induced NETs due to secreted C. albicans proteins.
Found at: doi:10.1371/journal.ppat.1000639.s004 (4.12 MB TIF)
Figure S5 Calprotectin-deficient mice release similar amounts of
NETs as wild-type mice in vitro and in vivo. (A) NET-DNA release
was induced with PMA and measured by Sytox Green
TM. There
were no significant differences between calprotectin-deficient and
wild type mouse neutrophils. (B) H & E stain of an abscess section
from calprotectin-deficient mice, 6 days after infection. NETs are
indicated by arrows, scale bar=50mm. (C–F) Confocal images of
indirect immunofluorescence with antibodies against (C) S100A9
(red), (D) MPO (green), (E) histone (blue) and (F) superimposition
of all signals. Arrows indicate NETs. No stain can be detected for
the anti-S100A9 antibody verifying its specificity. Scale
bar=50 mm. (G) Neutrophil recruitment was counted from
images of representative abscess sections for calprotectin-deficient
and wild type mice and calculated as neutrophils/area (mm
2).
Shown are means m s.d. of triplicates from three independent
abscesses per group.
Found at: doi:10.1371/journal.ppat.1000639.s005 (4.10 MB TIF)
Figure S6 C. albicans infection spread after subcutaneous
challenge in calprotectin-deficient but not in wild type mice. In
calprotectin-deficient mice, abscess lesions spread to other
locations in approximately 30% of the infected animals (n=10).
Spreading did not occur in wild type animals. (A) Shown are
representative abscesses from a calprotectin-deficient and (B) from
a wild type mouse at day 21 p.i.
Found at: doi:10.1371/journal.ppat.1000639.s006 (5.00 MB TIF)
Text S1 Supporting Methods
Found at: doi:10.1371/journal.ppat.1000639.s007 (0.05 MB
DOC)
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